| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.002 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.002 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.094 | 0.002 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.002 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.14 | 0.003 |